Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Файв Прайм Терапьютикс, Инк.filedCriticalФайв Прайм Терапьютикс, Инк.
Priority claimed from PCT/US2019/056210external-prioritypatent/WO2020081497A1/en
Publication of EA202190818A1publicationCriticalpatent/EA202190818A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
В настоящем изобретении представлены способы введения антител и их антигенсвязывающих фрагментов, которые специфически связываются с B7-H4 человека, субъекту, нуждающемуся в этом, например пациенту с онкологическим заболеванием, в комбинации с антагонистом PD-1/PD-L1, таким как антитело к PD-1.The present invention provides methods of administering antibodies and antigen-binding fragments thereof that specifically bind to human B7-H4 to a subject in need thereof, for example a patient with cancer, in combination with a PD-1 / PD-L1 antagonist such as an anti-PD antibody -one.
EA202190818A2019-05-302019-10-15
COMBINED THERAPY FOR CANCER
EA202190818A1
(en)